High-Dose Vitamin D Supplements Significantly Reduce ICU Admissions & COVID-19 Deaths

Conclusion Vitamin D, 200,000 IU dose in single or divided doses is safe and highly cost-effective in reducing complications and deaths in persons with SARS-CoV-2 infection. Early use of vitamin D (100,000 to 600,000 IU) can reduce ICU admissions by ~80%. Therefore, vitamin D can greatly reduce the need for expanding ICU beds AND cost less than 0.001% of using an ICU bed/day. Additional information regarding bolus D3 and oral calcifediol: There is little vitamin D3 (cholecalciferol) in food and multivitamins, including fortified food. Without passing through glass or sunscreen, skin exposure to ultraviolet-B from high-elevation sunlight can produce sufficient D3 for bone and immune system health. However, low elevation sunlight in winter, clouds, pollution, clothing cover, melanin-rich skin and concerns about skin cancer mean that most people are vitamin D deficient unless they take vitamin D supplements. Conversion of D3 in the liver to the circulating form, 25(OH)D, and for the immune cells to function takes two to five days. 25(OH)D is measured in the blood test and has a half-life of ~three weeks. Recent research shows that the immune system requires at least 40 ng/ml (100 nmol/L) circulating 25(OH)D to support autocrine (inside each cell) and paracrine (to nearby cells) signalling. Please refer to the research articles at: https://vitamindstopscovid.info/02-autocrine/. In the long term, such levels can be attained, on average for 70 kg adults, with 0.125 mg (5,000 IU) D...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Featured Global Headlines Health Human Rights Humanitarian Emergencies Sustainability TerraViva United Nations Source Type: news